Return to study ST002126 main page

Samples for study ST002126

Species: Mus musculus (Factor headings shown in green)
mb_sample_id Subject name Sample name Source_Name[gating] Treatment Batch Note Sample_Data:RAW_FILE_NAME
SA204362-HSC_5FU_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-1.cdf
SA204363-HSC_5FU_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-2.cdf
SA204364-HSC_5FU_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-fu-3.cdf
SA204366-HSC_5FU_ND_0h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-0h-1.cdf
SA204365-HSC_5FU_ND_0h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-0h-2.cdf
SA204367-HSC_5FU_ND_0h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-0h-3.cdf
SA204368-HSC_5FU_ND_12h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-12h-1.cdf
SA204370-HSC_5FU_ND_12h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-12h-2.cdf
SA204369-HSC_5FU_ND_12h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-12h-3.cdf
SA204373-HSC_5FU_ND_6h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-6h-1.cdf
SA204372-HSC_5FU_ND_6h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-6h-2.cdf
SA204371-HSC_5FU_ND_6h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nd-6h-3.cdf
SA204377-HSC_Ctrl_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-1.cdf
SA204378-HSC_Ctrl_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-2.cdf
SA204379-HSC_Ctrl_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig2.B, Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig2.K, Fig5J).hsc-ct-3.cdf
SA204374-HSC_Ctrl_NR_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, NR-treatment 8 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-ct-nr-1.cdf
SA204375-HSC_Ctrl_NR_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, NR-treatment 8 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-ct-nr-2.cdf
SA204376-HSC_Ctrl_NR_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) HSC Basal or Ctrl, NR-treatment 8 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-ct-nr-3.cdf
SA204382-HSC_5FU_NR_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-fu-nr-1.cdf
SA204381-HSC_5FU_NR_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-fu-nr-2.cdf
SA204380-HSC_5FU_NR_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 1 h 1c [13C, 15N] AAs were used for AA uptake (Fig5M); unlabeled AAs and TCA substrate were used for total AA levels (Fig2.C, Fig5K) and TCA substrate levels (Fig5J).hsc-fu-nr-3.cdf
SA204384-HSC_5FU_NR_0h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-0h-1.cdf
SA204385-HSC_5FU_NR_0h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-0h-2.cdf
SA204383-HSC_5FU_NR_0h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 0 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-0h-3.cdf
SA204388-HSC_5FU_NR_12h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-12h-1.cdf
SA204387-HSC_5FU_NR_12h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-12h-2.cdf
SA204386-HSC_5FU_NR_12h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 12 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-12h-3.cdf
SA204391-HSC_5FU_NR_6h_1Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-6h-1.cdf
SA204389-HSC_5FU_NR_6h_2Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-6h-2.cdf
SA204390-HSC_5FU_NR_6h_3Lin– Scal1+ c-Kit+ CD48– CD150+ (HSC) NR 8 weeks, 5 FU 2 weeks, [13C, 15N] AAs were incorporated for 24 h and subsequently washed out for 6 h 1d [13C, 15N] AA levels and [13C]TCA substrate levels in different time point were calculated for AA catabolism (Fig5.L).hsc-fu-nr-6h-3.cdf
  logo